Simvastatin suppresses mTOR signaling, triggers mitochondrial translocation of Parkin and p62/SQSTM1, activates mitophagy, and reduces the infarct area in mouse and HL-1 cell models of myocardial infarction. The gene discussed is SQSTM1; the disease is myocardial infarction.